Breast tissue diagnosis by Raman spectroscopy

Similar documents
Journal of Molecular Structure

RSNA, /radiol Appendix E1. Methods

Original Article Detection of lymph node metastases in cholangiocanma by fourier transform infrared spectroscopy

Human breast tissue cancer diagnosis by Raman spectroscopy

DETECTION OF BREAST & CERVICAL CANCER USING RAMAN SPECTROSCOPY

Raman spectroscopic signature of semen and its potential application to forensic body fluid identification

Breast pathology. 2nd Department of Pathology Semmelweis University

Use of a Protease Activated System for Real-time Breast Cancer Lumpectomy Margin Assessment

Imaging in breast cancer. Mammography and Ultrasound Donya Farrokh.MD Radiologist Mashhad University of Medical Since

HISTOMORPHOLOGICAL SPECTRUM OF BREAST LESIONS

Multimodal Spectroscopic Tissue Scanner for diagnosis of ex vivo surgical specimens

Diseases of the breast (1 of 2)

Guidance on the management of B3 lesions

Spectroscopic Analysis of Bladder Cancer Tissues Using Laser Raman Spectroscopy

Chapter 5. Oxygenated Hemoglobin Diffuse Reflectance Ratio for In Vivo Detection of oral Pre-cancer

Sickle Cell. Scientific Investigation

Development and application of novel spectroscopic tools for breast cancer diagnosis

Breast Pathology. Breast Development

Histopathological Spectrum of Neoplastic and Non-neoplastic Breast Lesions: A Two Years Study

Lesion Imaging Characteristics Mass, Favoring Benign Circumscribed Margins Intramammary Lymph Node

Using Infrared and Raman Microspectroscopies to Compare Ex Vivo Involved Psoriatic Skin and Normal Human Skin

Supplementary Information. Detection and delineation of oral cancer with a PARP1 targeted optical imaging agent

Noninvasive Blood Glucose Analysis using Near Infrared Absorption Spectroscopy. Abstract

A712(19)- Test slide, Breast cancer tissues with corresponding normal tissues

Food protein powders classification and discrimination by FTIR spectroscopy and principal component analysis

Pitfalls and Limitations of Breast MRI. Susan Orel Roth, MD Professor of Radiology University of Pennsylvania

INTRA-OPERATIVE CYTOLOGY AND FROZEN SECTIONS OF BREAST LESIONS: A COMPARISON FROM A SAUDI TEACHING HOSPITAL

Optimizing Breast Sonography

Raman Spectroscopy and imaging to explore skin and hair. What is the Raman scattering effect?

Raman Spectroscopy of Normal and Diseased Human Breast Tissues

Flat Epithelial Atypia

Fluorescence spectroscopy and microscopy of cutaneous tumours correlation between micro- and macro- spectral measurements

Treatment options for the precancerous Atypical Breast lesions. Prof. YOUNG-JIN SUH The Catholic University of Korea

1. Clinical breast exam. 2. Imaging. 3. Biopsy ELASTOGRAPHY. Triple assessment. Overdiagnosed!?

Non-mass Enhancement on Breast MRI. Aditi A. Desai, MD Margaret Ann Mays, MD

Chapter 8. 5-ALA Induced PpIX Fluorescence in Oral Cancer Detection In Vivo

Using Near-Infrared Light To Detect Breast Cancer

Highly specific recognition of breast tumors by an RNA-cleaving fluorogenic DNAzyme probe

Fast 3D Optical Mammography using ICG Dynamics for Reader-Independent Lesion Differentiation

Papillary Lesions of the breast

International Journal of Health Sciences and Research ISSN:

Armed Forces Institute of Pathology.

Diagnostic des maladies du foie par spectroscopie et imagerie multimodale

Trans Fat Determination in the Industrially Processed Edible Oils By Transmission FT-IR Spectroscopy By

Challenges in Rapid Evaporative Ionization of Breast Tissue: a Novel Method for Realtime MS Guided Margin Control During Breast Surgery

Image guided core biopsies:

BREAST PATHOLOGY. Fibrocystic Changes

Detailed Program of the second BREAST IMAGING AND INTERVENTIONS PROGRAM am am : Clinician s requirements from breast imaging

RAMAN SPECTROSCOPY OF ARTICULAR CARTILAGE AND SUBCHONDRAL BONE ON OSTEOARTHRITIC HUMAN FEMORAL HEADS

Fluorescence Spectroscopy: A New Approach in Cervical Cancer

BREAST MRI. VASILIKI FILIPPI RADIOLOGIST CT MRI & PET/CT Departments Hygeia Hospital, Athens, Greece

Papillary Lesions of the Breast A Practical Approach to Diagnosis. (Arch Pathol Lab Med. 2016;140: ; doi: /arpa.

Rare Breast Tumours. 1. Breast Tumours. 1.1 General Results. 1.2 Incidence

OPTICAL SPECTROSCOPY FOR THE EVALUATION OF SURGICAL MARGIN STATUS FOLLOWING BREAST CANCER RESECTION. Matthew David Keller.

Common Raman Spectral Markers among Different Tissues for Cancer Detection

3/28/2017. Disclosure of Relevant Financial Relationships. GU Evening Subspecialty Case Conference. Differential Diagnosis:

Supporting Information

LARYNGEAL DYSPLASIA. Tomas Fernandez M; 3 rd year ENT resident, Son Espases University Hospital

C be diagnosed radiographically before it is

K. M. Sorensen Utah State University, Logan, Utah

HISTOPATHOLOGICAL EVALUATION OF BENIGN PROLIFERATIVE BREAST LESIONS

FTIR Spectroscopic Analysis of Normal and Cancerous Human Breast Tissues between 450 Cm -1 and 1100 Cm -1 using Trend Analysis

Raman spectroscopy of chocolate bloom

Does elastography change the indication to biopsy? IBDC

Wellness Along the Cancer Journey: Cancer Types Revised October 2015 Chapter 2: Breast Cancer

An optical dosimeter for the selective detection of gaseous phosgene with ultra-low detection limit

PAAF vs Core Biopsy en Lesiones Mamarias Case #1

Ultrasound of the Breast BASICS FOR THE ORDERING CLINICIAN

SOORYA PETER IVEN JOSE CHRIST UNIVERSITY FACULTY OF ENGINEERING. Excerpt from the Proceedings of the 2014 COMSOL Conference in Bangalore

Successful Breast MRI Program : The ingredients

Clinical outcomes of patients treated with accelerated partial breast irradiation with high-dose rate brachytherapy: Scripps Clinic experience

I. INTRODUCTION. environment of cell and tissues [2].

A712(18)- Test slide, Breast cancer tissues with corresponding normal tissues

Vibrational Microspectroscopy of Skin: Applications to Pharmacology and Biochemistry. Rich Mendelsohn Rutgers University

FURTHER STUDY OF SPECTRUM FROM STOMACH CANCER SERUM EMISSION

Synchronous squamous cell carcinoma of the breast. and invasive lobular carcinoma

DISORDERS OF THE BREAST Dated. FIBROADENOSIS Other common names: mastitis, fibrocystic disease, cystic mammary dysplasia.

MALDI-IMS (MATRIX-ASSISTED LASER DESORPTION/IONIZATION

Chapter 12: Mass Spectrometry: molecular weight of the sample

Emerging Techniques in Breast Imaging: Contrast-Enhanced Mammography and Fast MRI

Evaluation of BI-RADS 3 lesions in women with a high risk of hereditary breast cancer.

Braster in-home breast examination system

Index. C Calcifications fat necrosis 1, 61 fat necrosis 4, 69 nipple/peri-areolar involvement 1, 165

Radiologic and pathologic correlation of non-mass like breast lesions on US and MRI: Benign, high risk, versus malignant

Radiologic and pathologic correlation of non-mass like breast lesions on US and MRI: Benign, high risk, versus malignant

Supporting Information

Ductal Carcinoma in Situ. Laura C. Collins, M.D. Department of Pathology Beth Israel Deaconess Medical Center and Harvard Medical School Boston, MA

Optimal Differentiation of Tissue Types Using Combined Mid and Near Infrared Spectroscopy

Novel Optical Research at UPMC

Defense Technical Information Center Compilation Part Notice

Evolution of diagnostic ultrasound systems Current achievements in breast ultrasound

Jpn J Med Ultrasonics Vol 32 No

In vivo Infrared Spectroscopy

Investigation of thermal degradation of vegetable oils by spectroscopic methods and its mathematical analysis

Breast Disease: What PCPs Need to Know. Eunice Cho MD FACS

Diffuse reflectance spectral detection of stress-induced stomach ulcers in animal models

Case study 1. Rie Horii, M.D., Ph.D. Division of Pathology Cancer Institute Hospital, Japanese Foundation for Cancer Research

Next-Generation Immunohistochemistry: Multiplex tissue imaging with mass cytometry

A NEW BIOMARC TISSUE MARKER FOR BREAST BIOPSY: CLINICAL EVALUATION IN ULTRASOUND, MAMMOGRAPHY, CT SCANNING AND BREAST MRI

Select problems in cystic pancreatic lesions

Transcription:

Breast tissue diagnosis by Raman spectroscopy B. Brożek-Płuska*, J.Surmacki*, J. Jabłońska**, R. Kordek**, H. Abramczyk* *Laboratory of Laser Molecular Spectroscopy, Institute of Applied Radiation Cemistry, Tecnical University of Łódź, Faculty of Cemistry, Poland **Department of Oncology, Medical University of Łódź, Poland

GOAL Some substances are produced by te organism in response to te cancer s presence. Tey are called tumor markers. Tumor markers are molecules occurring in blood or tissue tat are associated wit cancer and wose measurement or identification is useful in patient diagnosis or clinical management. Te ideal marker would be a blood test for cancer in wic a positive result would occur only in patients wit malignancy, one tat would correlate wit stage and response to treatment and tat was easily and reproducibly measured. No tumor marker now available as met tis ideal. We believe tat optical metods including Raman spectroscopy will provide suc a marker. Possibly it will elp to find te allmarks of cancer.

Wy? immediate in vivo diagnosis reduction te number of biopsies combination of biocemical and istopatological diagnosis provides more information because patology is intimately related to biocemistry metod as a potential to remove uman interpretation non-invasive,non-ionizing metod tat probes wit cemical specificity vibrations and fluorescence (not just structure) extremaly ig spatial resolution (optical imaging)

Intensity (arbitrary units) Intensity (arbitrary units) Tissue Preparation carcinoma mammae fibroadenoma mammae 514nm, 1mW, cancer 2 1 2 26 24 22 2 15 1 maligant tissue 18 16 5 14 12 35 3 25 2 15 1 normal tissue 514nm, normal tissue 1mW 25mW 5 5 1 15 2 25 3 35 4 Raman sift in wavennumbers [cm -1 ] 5 1 15 2 25 3 35 4 Raman sift in wavennumbers [cm -1 ] 8 5 6 4 2 Human speciemens obtained from surgery. Upon removal during te operation, te ex vivo sample is devided by a doctor into two parts, one goes to our lab te second goes to te patology examination Te ex vivo samples are neiter frozen in liquid nitrogen for storage nor fixed in formalin, te fres tissue is measured immeditely after delivering from te ospital Te samples for patology measurements are passively tawed at room temperature and kept moist wit PBS fixed in formalin Cut troug te marked locations into 5-μm-tick sections, and stained wit eosin

Measurements Parameters Te laser excitation is 514 nm, te spot is d=5 μm in diameter Ligt diffusion in te tissue results in a spot of v 1mm Integration time.5 s Spectral resolution 2 and 8 cm -1 Te laser excitation power: 25 mw, 1mW

Intensity [counts/s] Intensity [counts/s] Patients Statistics 4 14 KT - normal tissue 11 spectra from 1 patients 3 2 fibroadenomas infiltrating carcinoma infiltrating ductal carcinoma (IDC) infiltrating lobular carcinoma (ILC) IDC+ILC multifocal carcinoma carcinoma microinvasive intracystic papillary carcinoma (noninvasive) carcinoma mucinosum carcinoma intraductal microinvasive benign dysplasia dysplasia benign dysplasia (cystes, apocrinal metaplasia, adenosis) ductal-lobular yperplasia cystic mastopaty 1 25mW 1 2 3 4 5 6 7 8 relative wavenumber [cm -1 ] 514 541 572 67 647 691 743 82 872 [nm] 4 3 2 1 14 KT - carcinoma lobulare infiltrans mammae 25mW 1 2 3 4 5 6 7 8 relative wavenumber [cm -1 ] 514 541 572 67 647 691 743 82 872 [nm]

Intensity [counts/s] Intensity [counts/s] Comparison between te Raman spectra for normal and malignant tissue (infiltrating ductal carcinoma (IDC)) 15 6 KT - normal tissue 15 6 KT - carcinoma ductale infiltrans G2 125 125 1 75 5 25 25mW 1 2 3 4 5 6 7 8 relative wavenumber [cm -1 ] 514 541 572 67 647 691 743 82 872 [nm] 1 75 5 25 25mW 1 2 3 4 5 6 7 8 relative wavenumber [cm -1 ] 514 541 572 67 647 691 743 82 872 [nm]

intensity (cts/s) intensity 9cts/s) Quencing of autofluorescence by low temperature Raman spectroscopy 25 2 normal tissue - patient nr 9 K9T33-25K K9T34-2K K9T35-17K K9T36-15K K9T37-11K K9T38-77K 6 5 cancer tissue - patient nr 9 K9T14-25K K9T15-2K K9T16-17K K9T17-15K K9T18-11K K9T19-77K 15 4 1 3 2 5 1-5 5 1 15 2 25 3 35 4-1 5 1 15 2 25 3 35 4 wavenumber (cm-1) wavenumber (cm-1)

Y Axis Title intensity [cts/s] Comparison between te Raman spectra for normal and malignant tissue (carcinoma mucinosum ) 5 K14T2 (carcinoma mucinosum mammae sinistri) K14T2 (normal tissue) 45 4 35 3 25 2 15 1 5-5 2 4 6 8 wavenumber X Axis [1/cm] Title

Y Axis Title intensity [cts/s] Comparison between te Raman spectra for normal and benign tumour tissue (fibroadenoma) 18 K31T5 (normal tissue) K31T8 (Fibroadenoma mamae) 16 14 12 1 8 6 4 2 2 4 6 8 X Axis Title wavenumber [1/cm]

PRINCIPAL COMPONENT ANALYSIS (PCA) PLS_Toolbox Version 4. for use wit MATLAB Barry M. Wise Neal B. Gallager Rasmus Bro Jeremy M. Saver Willem Windig R. Scott Koc Eigenvector Researc, Inc. 395 West Eaglerock Drive Wenatcee, WA 9881 elpdesk@eigenvector.com www.eigenvector.com

Scores on PC 2 (7.7%) PCA score plot mean center, SNV, 1-st derivative Low autofluorescence.4.2 -.2 -.4 -.6 -.8-1 -1.2 w w w c w c w w c w w w c c c c w w c c c c c c c w w c w c Normal tissue c c Malignant tissue c c Samples/Scores Plot of HY Benign tissue 6 5 4 3 2 1 Decluttered No Raman peaks -1.4-1 -.5.5 1 1.5 2 Hig autofluorescence Scores on PC 1 (66.25%) Intensive Raman peaks 12

Loadings on PC 1 (66.25%) PCA loading plot mean center, SNV, 1-st derivative.2 Variables/Loadings Plot for HY 1.15.1 C-C and C=C stretcing carotenoids C-H strecing lipids.9.8.7.5.6.5 -.5.4 -.1.3.2 -.15.1 -.2 5 1 15 2 25 3 35 wavenumber (cm-1)

CONCLUSIONS Te results clearly illustrates te ability of Raman spectroscopy to accurately diagnose breast cancer and demonstrates ow te diagnostic sceme can be adjusted to obtain te desired degree of sensitivity and specificity (88%,72%) Te normal tissue as a caracteristic bands: C-C (111 cm -1 ) and C=C (152 cm -1 ) stretcing bands of carotenoids and at 284-29 cm -1 for te C-H symmetric and asymmetric bands of lipids (fat) wic are not visible in te malignant tissue and in benign tumor tissue. Moreover, te fluorescence is muc iger in te malignant tissue. We belive tat in a very near future a good quality Raman signal will be obtained wit te optical fibers coupled wit a biopsy needle and incorporated into Raman spectrometer for breast tissue measurements in vivo.